Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FOLD Amicus Therapeutics > Detailed Quotes

FOLD Amicus Therapeutics

10.280
-0.410-3.84%
Close 09/29 16:00 ET
10.2800.0000.00%
Post Mkt Price 09/29 16:59 ET
High
10.685
Open
10.560
Turnover
23.80M
Low
10.150
Pre Close
10.690
Volume
2.32M
Market Cap
2.88B
P/E(TTM)
Loss
52wk High
12.960
Shares
280.50M
P/E(Static)
Loss
52wk Low
5.910
Float Cap
2.07B
Bid/Ask %
0.00%
Historical High
25.390
Shs Float
201.63M
Volume Ratio
1.20
Historical Low
1.765
Dividend TTM
--
Div Yield TTM
--
P/B
16.63
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.15%
Amplitude
5.01%
Avg Price
10.276
Lot Size
1
Float Cap
2.07B
Bid/Ask %
0.00%
Historical High
25.390
Shs Float
201.63M
Volume Ratio
1.20
Historical Low
1.765
Dividend TTM
--
P/B
16.63
Dividend LFY
--
Turnover Ratio
1.15%
Amplitude
5.01%
Avg Price
10.276
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Philadelphia, PA.
CEO: Mr. Bradley L. Campbell
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...